Deucrictibant for angioedema due to acquired C1-inhibitor deficiency: A randomized-controlled trial. Petersen RS, Fijen LM, Kelder JP, Cohn DM, et al. J Allergy Clin Immunol 2024;154:179-183.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Petersen RS, Fijen LM, Kelder JP, Cohn DM, et al. Deucrictibant for angioedema due to acquired C1-inhibitor deficiency: A randomized-controlled trial. J Allergy Clin Immunol 2024;154:179-183.
PMID: 38494092